Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention

Autor: Alessandro Mandurino-Mirizzi, Patrizia Caprari, Serena Panicale, Giampaolo Niccoli, Filippo Crea, Vincenzo Vetrugno, Francesco Fracassi, Nicola Cosentino
Rok vydání: 2018
Předmět:
Erythrocyte Aggregation
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Blood viscosity
030204 cardiovascular system & hematology
Coronary Angiography
Angina
Electrocardiography
Necrosis
03 medical and health sciences
Percutaneous Coronary Intervention
0302 clinical medicine
Risk Factors
Internal medicine
Humans
Medicine
Angina
Stable

Prospective Studies
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
Non-ST Elevated Myocardial Infarction
Prospective cohort study
Aged
Aged
80 and over

medicine.diagnostic_test
business.industry
Myocardium
Percutaneous coronary intervention
General Medicine
Middle Aged
Blood Viscosity
medicine.disease
Treatment Outcome
Hemorheology
Conventional PCI
Cardiology
ST Elevation Myocardial Infarction
Female
Cardiology and Cardiovascular Medicine
business
Zdroj: Coronary Artery Disease. 29:638-646
ISSN: 0954-6928
DOI: 10.1097/mca.0000000000000661
Popis: BACKGROUND Abnormal blood viscosity favors atherosclerosis owing to endothelial dysfunction and changes in shear stress. Its effect on coronary microvasculature during percutaneous coronary intervention (PCI) is still unknown. We aimed to investigate the role of hemorheological parameters in the incidence of microvascular obstruction (MVO) and the periprocedural necrosis after primary or elective PCI, and secondarily, we evaluated their prognostic significance. MATERIALS AND METHODS We enrolled 25 patients with ST-elevation myocardial infarction (STEMI), 30 patients with non-ST-elevation myocardial infarction (NSTEMI), and 30 patients with stable angina (SA) undergoing PCI. MVO in patients with STEMI and periprocedural necrosis in patients with NSTEMI and those with SA were assessed using angiographic/electrocardiographic and laboratory methods, respectively. Hemorheological profile included blood viscosity (η) at shear rates 200 s and 1 s, the erythrocyte aggregation index (η1/η200), and plasma viscosity. Major adverse cardiovascular events occurrence was evaluated at follow-up. RESULTS Patients with STEMI experiencing angiographic MVO (28%) had higher η200 (5.42±1.28 vs. 3.98±1.22 mPa[BULLET OPERATOR]s; P=0.015). Similarly, patients with STEMI experiencing electrocardiographic MVO (56%) had higher η200 (4.58±0.36 vs. 3.94±0.19 mPa[BULLET OPERATOR]s; P
Databáze: OpenAIRE